Contact and place of performance
Lendorph Ramos
JBSA Ft Sam Houston, Texas 78234
Notice of Intent The Naval Medical Logistics Command (NMLC) intends to award a sole source contract under the authority of FAR 16.5 to Diagnostica Stago Inc. of 5 Century Drive Suite 1 Parsippany, NJ 07504-4607 44106-1712 for the delivery of the described requirement in support of the Naval Medical Research Unit San ANTONIO (NAMRU-SA), The requirement is for research in hemorrhagic shock and resuscitation research. P...
View moreThe contractor must be able to provide for the delivery per period of performance of up to 6 STA PTT-A, 12 STA Liatest D-di, 12 STA Stachrom AT III, 6 STA Neoplastin CI +10, 6 STA Fibrinogen 5, 12 STA Liatest VWF:AG, 10 STA Deficient II, 10 STA Deficient V, 10 STA Deficient VII, 10 STA Deficient VIII, 10 STA Deficient IX, 10 STA Deficient X, 10 STA Deficient XII, 6 STA CaCL2 0.025M, 5 STA Owren Koller, 5 STA VWF:AG Calibrator, 5 STA Liatest Control N+P, 6 STA Unicalibrator, 8 STA System Control N+P, 16 STA Desorb U, 4 STA Cleaner Solution, 5 STA Mini Reducer, 5 STA Maxi Reducer, 5 Microcontainer, 5 Microcups, 6 STA Cuvette, 6 STA Stachrom Plasminogen, 6 Plasminogen Activator Inhibitor, 6 STA Clot VIIa, 6 STA Liatest Fibrin Monomer, 6 Factor XIII, 6 Protein C Clot, 6 STAChrom Protein C, 6 Free Protein S, 6 STA Fibrin Monomer Calibrator, 6 STA Fibrin Monomer Control, 6 K-Assay XIII Calibrator, 6 K-Assay Factor XIII Control, and up to $10,000 in shipping costs per period of performance. The period of performance for this agreement is anticipated to be a base period of 12 months, followed by four 12-month option periods for a total of 60 months.
NAICS Code: 339112 - Surgical and Medical Instrument Manufacturing. The small business size standard, for NAICS Code 339112, is 1,000 employees.
There are no set aside restrictions for this requirement. This notice of intent is not a request for competitive proposals and no solicitation document exists for the requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work. Capability statements shall not exceed 1 (8.5 x 11 inch) page using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source contract.
Capability statements are due by 11:00 AM Eastern Time, 01 November 2022. Capability statements shall be submitted by e-mail ONLY as a Microsoft Word, Microsoft Excel or Adobe PDF attachment to Mr. Lenny Ramos at the following e-mail address: [email protected] and CC Mr. Ronald Govans at [email protected]
The Naval Medical Logistics Command intends to award a sole source contract to Diagnostica Stago Inc. for the delivery of reagents and disposable supplies in support of the Naval Medical Research Unit San Antonio (NAMRU-SA) at JBSA Fort Sam Houston, Texas. This requirement supports ongoing research regarding hemorrhagic shock and resuscitation, specifically evaluating the intrinsic and extrinsic coagulation status of research subjects. The acquisition involves products validated for hemostasis and coagulation analysis on the STA Compact Max analyzer. Utilizing these specific materials is necessary to maintain continuity with historical data and ongoing research models, as alternative materials would invalidate outcomes for future research protocols.
The contractor is required to provide various reagents and supplies, including STA PTT-A, Liatest D-di, Stachrom AT III, Neoplastin CI +10, and Fibrinogen 5, among other specialized diagnostic components and reducers. The anticipated period of performance consists of a 12-month base period followed by four 12-month option periods, totaling 60 months. This procurement is identified by solicitation number N6264523R0003 and falls under NAICS code 339112 Surgical and Medical Instrument Manufacturing and PSC 6515 MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES.
There are no set-aside restrictions for this requirement. Although this notice of intent is not a request for competitive proposals, the government will consider capability statements submitted by the response deadline of November 1, 2022. Statements must demonstrate the ability to perform the work in one page or less and be submitted via email to Lendorph Ramos. Documentation related to this notice includes a Notice of Intent and a Statement of Work.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.